World-first 3D Printed Esophageal Stents developed

New 3D printed stents developed by researchers deliver breakthrough treatment for esophageal cancer.

New 3D printed stents developed by University of South Australia researchers deliver breakthrough treatment for esophageal cancer.

Fabricated from polyurethane filament and incorporating the chemotherapy drug 5-fluorouracil (5-FU), //the new esophageal stents are the first to contain active pharmaceutical ingredients within their matrix .

Esophageal Cancer - Types, Risk factors, Symptoms, Diagnosis, Treatment, Prevention, Prognosis
Esophageal cancer refers to malignancy of the food pipe which connects the throat to the stomach. It typically presents with difficulty in swallowing.

‘World-first 3D printed esophageal stents developed by the researchers could revolutionize chemotherapy drugs delivery to provide more accurate, effective and personalized treatment for esophageal cancer patients. ’

Their unique composition allows them to deliver up to 110 days of a sustained anti-cancer medication directly to the cancer site, restricting further tumor growth.

Importantly, the capabilities of 3D printing enabling rapid creation of individually tailored stents with patient-specific geometries and drug dosages.

PhD scholar, UniSA's Paris Fouladian, says the new esophageal stents could be a gamechanger for treating esophageal cancer.

Esophageal Cancer Patients Show Abundance of Oral Pathogens, Says Study
In esophageal cancer patients, oral pathogens are more prevalent and could be used as a novel diagnostic tool, said researchers.

"Esophageal cancer is often challenging to treat, with early diagnosis critical for positive outcomes," Fouladian says.

"The most prominent symptom is dysphagia (difficulty swallowing food or drink) which is due to malignant cancer cells blocking the esophagus.

Immunotherapy Is Beneficial For Gastric and Oesophageal Cancers
Immunotherapy is found to be beneficial for patients with gastric and oesophageal cancers who currently have poor survival,reveals a recent study conducted at ESMO 2020.

"Blockages are commonly eased by an esophageal stent - a small tube that is placed in the food pipe to keep it open - but these too can become obstructed by invading cancer cells.

"Our new drug-loaded esophageal stents can help prevent further blockages by administering anti-cancer drugs directly to the tumor, limiting further growth while relieving the pressure of dysphagia."

Lymph Nodes Better at Predicting Patient Outcomes in Esophageal Cancer
Studying the response of lymph node to neoadjuvant chemotherapy is a better indicator of patient prognosis in esophageal cancer.

The new drug-loaded 3D printed esophageal stents are stable to both UV and gamma sterilization processes.

Esophageal cancer is the seventh most common cancer in the world, and the sixth highest cause of cancer deaths worldwide. Unless diagnosed early, prognosis remains poor with a five-year survival rate of around 20 per cent.

Senior researcher and Director of UniSA's Pharmaceutical Innovation and Development Group, Professor Sanjay Garg, says the new technology is a significant breakthrough in modern drug delivery.

"3D printing processes that combine medicines and medical devices are on the precipice of changing the way we deliver medicines," Prof Garg says.

"We're now exploring the potential of 3D printing to design precise and individualized drug delivery systems.

"While more research is needed to further test the new drug-loaded 3D printed stents, we're hopeful that this new technology will deliver positive outcomes for people with esophageal cancer."

Source-Eurekalert